Home › Funds › Stonepine Capital Management, LLC › PYXS
Stonepine Capital Management, LLC position in PYXS
PYXIS ONCOLOGY INC · Health Care
Stonepine Capital Management, LLC reported holding 689,000 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.23% of its reported portfolio and ranking #19 among its reported holdings. Stonepine Capital Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's PYXS position evolved
Stonepine Capital Management, LLC first disclosed a stake in PYXS in Q3 2026 at 689,000 shares (US$1.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 689.00K | $1.61M | New |
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 32 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $761.47K · Q3 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held PYXS?
Stonepine Capital Management, LLC has disclosed PYXS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Stonepine Capital Management, LLC's current position in PYXS?
As of Q3 2026, Stonepine Capital Management, LLC holds 689.00K shares of PYXS (PYXIS ONCOLOGY INC), valued at $1.61M, representing 1.23% of its reported portfolio and ranking #19.
Has Stonepine Capital Management, LLC been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC newly opened its position in PYXS.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.